US · GSIW · FINANCIAL - CAPITAL MARKETS
Garden Stage Limited (GSIW) intrinsic value and stock valuation
$10.03as of 2026-11-21 · Mkt cap 24.99M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Garden Stage Limited DCF and intrinsic value
InvestorsCraft values GSIW with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from GSIW’s statements →
Garden Stage Limited Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2021–2026, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $7.28M | $5.4M | $1.36M | $420K | $300K |
| Operating income | -$-13.86M | -$-4.32M | -$-4.58M | -$-30K | -$-70K |
| Net income | -$-13.84M | -$-4.32M | -$-4.59M | -$-30K | -$-70K |
| EPSd | -$-1.38M | -$-19.75K | -$-24.09K | -$140.52 | -$327.87 |
| Operating cash flow | -$-4.23M | -$-1.15M | -$-7.09M | -$-240K | -$-890K |
| Capital expenditure | -$-100K | -$-220K | -$0.00 | -$0.00 | -$0.00 |
| Free cash flow | -$-4.34M | -$-1.37M | -$-7.09M | -$-240K | -$-890K |
| Total assets | $41.9M | $15.9M | $16.6M | $1.67M | $1.31M |
| Total debt | $80K | $200K | $290K | $10K | $20K |
| Net debt | -$-17.44M | -$-430K | -$-2.38M | -$-800K | -$-980K |
| Total equity | $24.2M | $6.7M | $9.29M | $250K | $20K |
| Cash and short-term investments | $17.6M | $620K | $2.67M | $800K | $1M |
Income statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $7.28M | $5.4M | $1.36M | $420K | $300K |
| Cost of revenue | $6.55M | $5.15M | $3.36M | $40K | $110K |
| Gross profit | $730K | $260K | -$-1.99M | $380K | $180K |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $0.00 | $4.42M | $2.62M | $1.15M | $530K |
| Other expenses | $14.6M | $160K | $20K | $0.00 | $0.00 |
| Operating expenses | $14.6M | $4.58M | $2.63M | $1.11M | $540K |
| Cost and expenses | $21.1M | $9.73M | $5.98M | $440K | $360K |
| Interest income | $750K | $60K | $40K | $50K | $60K |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation and amortization | $1.22M | $170K | $80K | $10K | $0.00 |
| Ebitda | -$-12.64M | -$-4.16M | -$-4.54M | -$-20K | -$-60K |
| Operating income | -$-13.86M | -$-4.32M | -$-4.58M | -$-30K | -$-70K |
| Total other income/expenses, net | $0.00 | $50K | $0.00 | $180K | $440K |
| Income before tax | -$-13.86M | -$-4.27M | -$-4.58M | -$-30K | -$-70K |
| Income tax expense | -$-20K | $40K | $10K | -$0.00 | $0.00 |
| Net income | -$-13.84M | -$-4.32M | -$-4.59M | -$-30K | -$-70K |
| Weighted average shares outstanding | $10M | $218.8M | $190.6M | $213.5M | $213.5M |
| Weighted average diluted shares outstanding | $10M | $218.8M | $190.6M | $213.5M | $213.5M |
Balance sheet
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $17.6M | $620K | $2.67M | $800K | $1M |
| Net receivables | $8.76M | $1.73M | $870K | $6.11M | $2.05M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $9.94M |
| Total current assets | $26.3M | $13.8M | $12.3M | $12.5M | $9.94M |
| Property, plant and equipment, net | $250K | $350K | $300K | $10K | $20K |
| Goodwill and intangible assets | $11.1M | $60K | $60K | $60K | $60K |
| Long-term investments | $0.00 | $0.00 | $0.00 | $540K | $0.00 |
| Total non-current assets | $15.6M | $2.13M | $4.33M | $630K | $300K |
| Total assets | $41.9M | $15.9M | $16.6M | $1.67M | $1.31M |
| Accounts payable | $0.00 | $8.43M | $6.91M | $10.3M | $7.86M |
| Short-term debt | $80K | $120K | $90K | $70K | $70K |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $90K | $0.00 |
| Total current liabilities | $80K | $9.12M | $7.1M | $11.2M | $10M |
| Long-term debt | $0.00 | $80K | $200K | $0.00 | $70K |
| Deferred revenue, non-current | $160K | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $17.6M | $80K | $200K | $1.42M | $70K |
| Capital lease obligations | $0.00 | $200K | $290K | $70K | $140K |
| Total liabilities | $17.7M | $9.2M | $7.3M | $1.42M | $1.29M |
| Common stock | $30K | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained earnings | -$-22.82M | -$-8.99M | -$-4.67M | -$-10K | $20K |
| Accumulated other comprehensive income (loss) | -$-310K | -$-30K | -$-10K | $0.00 | $0.00 |
| Total equity | $24.2M | $6.7M | $9.29M | $250K | $20K |
| Total investments | $30K | $0.00 | $0.00 | $540K | $0.00 |
| Total debt | $80K | $200K | $290K | $10K | $20K |
| Net debt | -$-17.44M | -$-430K | -$-2.38M | -$-800K | -$-980K |
Cash flow statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net income | -$-13.84M | -$-4.32M | -$-4.59M | -$-30K | -$-70K |
| Depreciation and amortization | $1.22M | $170K | $10K | $10K | $0.00 |
| Stock-based compensation | $0.00 | $1.68M | $1.87M | $0.00 | $0.00 |
| Change in working capital | $3.84M | $1.23M | -$-1.06M | -$-220K | -$-820K |
| Accounts receivable | -$-7.1M | -$-960K | $670K | -$-520K | $70K |
| Inventory | -$-950K | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | $8.6M | $1.38M | -$-440K | $310K | -$-890K |
| Net cash provided by operating activities | -$-4.23M | -$-1.15M | -$-7.09M | -$-240K | -$-890K |
| Investments in property, plant and equipment | -$-1.23M | -$-220K | -$0.00 | -$0.00 | -$0.00 |
| Acquisitions, net | -$-5.05M | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | -$-6.31M | -$-220K | -$0.00 | -$0.00 | -$0.00 |
| Common stock issued | $20.6M | $0.00 | $10.1M | $800K | -$0.00 |
| Common stock repurchased | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | $20.4M | $260K | $9.69M | $50K | -$0.00 |
| Net change in cash | $9.64M | -$-1.05M | $2.62M | -$-200K | -$-13.9M |
| Cash at end of period | $17.5M | $7.89M | $8.94M | $800K | $1M |
| Operating cash flow | -$-4.23M | -$-1.15M | -$-7.09M | -$-240K | -$-890K |
| Capital expenditure | -$-100K | -$-220K | -$0.00 | -$0.00 | -$0.00 |
| Free cash flow | -$-4.34M | -$-1.37M | -$-7.09M | -$-240K | -$-890K |
Line items
Line items
Line items
About Garden Stage Limited
Garden Stage Limited, through its subsidiaries, provides financial services in Hong Kong. It offers securities dealing and brokerage services; underwriting and placing services; investment advisory services; due diligence services; introduction and referral services; and asset management services, such as account and fund management services. The company was incorporated in 2022 and is headquartered in Central, Hong Kong. Garden Stage Limited is a subsidiary of Oriental Moon Tree Limited.
- CEO
- Sze Chan
- Employees
- 17
- Beta
- 3.96
Explore
Frequently asked questions
What is the intrinsic value of Garden Stage Limited (GSIW)?
Garden Stage Limited (GSIW) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is GSIW undervalued?
GSIW trades at a price of $10.03 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.